Proscia pricing
No price is published. The edition distinction matters and the company states it plainly: Concentriq AP-Dx is FDA cleared (K230839, K261380), Health Canada licensed and CE marked under the EU IVDR for primary diagnosis, while Concentriq AP and LS are research use only and not for clinical diagnosis, as are Proscia's AI applications; third party applications carry their makers' labeling. Slides that inform diagnoses belong on the cleared edition.
How Proscia pricing works
- Pricing model
- Undisclosed. Two editions serve two customer bases, clinical diagnostic laboratories and life sciences R&D organizations, almost certainly on different commercial structures.
- Implementation
- Not disclosed. Whole slide imaging deployment involves substantial storage and scanner integration considerations that are not addressed publicly.
- Business associate agreement
- Not published. The platform page states HIPAA alignment; no business associate agreement, tier or subcontractor terms are published for a vendor hosting diagnostic images for clinical laboratories on AWS.
The research editions are described as GxP ready for life sciences, a quality framework rather than a security or clinical credential. The AI portfolio page says every listed application is available through Proscia. The charging basis, how third party applications are billed and implementation cost are not published.
Proscia pricing against its alternatives
Published prices for Proscia and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.
- PProsciaNo published price
- IIndica LabsNo published price
- PPathAINo published price
- MMindpeakNo published price
- PPaigeNot published (owned by Tempus since August 2025)
- AaetherAINo published price
- VVisiopharmNo published price
- LLeica Aperio iQC DXNo published price
- PPramanaNo pricing published; scanner purchase or per image service, figures unstated
Proscia pricing, answered
How much does Proscia cost?
Proscia does not publish a price. The edition distinction matters and the company states it plainly: Concentriq AP-Dx is FDA cleared (K230839, K261380), Health Canada licensed and CE marked under the EU IVDR for primary diagnosis, while Concentriq AP and LS are research use only and not for clinical diagnosis, as are Proscia's AI applications; third party applications carry their makers' labeling.
Does Proscia charge an implementation fee?
Not disclosed. Whole slide imaging deployment involves substantial storage and scanner integration considerations that are not addressed publicly.
Does Proscia offer a business associate agreement?
Not published. The platform page states HIPAA alignment; no business associate agreement, tier or subcontractor terms are published for a vendor hosting diagnostic images for clinical laboratories on AWS.